deferoxamine has been researched along with Hyperplasia in 6 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nigri, GR | 1 |
| Kossodo, S | 1 |
| Waterman, P | 1 |
| Fungaloi, P | 1 |
| LaMuraglia, GM | 1 |
| Gates, JD | 1 |
| Hirsch, GM | 1 |
| Karnovsky, MJ | 1 |
| Blanco, LN | 1 |
| Frank, L | 1 |
| Davis, MG | 1 |
| Dalen, H | 1 |
| Austerheim, AM | 1 |
| Gulbrandsen, TF | 1 |
| Svendsen, E | 1 |
| Hagen, PO | 1 |
| Hermitte, L | 1 |
| Vialettes, B | 1 |
| Atlef, N | 1 |
| Payan, MJ | 1 |
| Doll, N | 1 |
| Scheimann, A | 1 |
| Vague, P | 1 |
| Terao, N | 1 |
| Suzuki, M | 1 |
| Homma, S | 1 |
| Asano, Y | 1 |
| Hosoda, S | 1 |
| Furuse, M | 1 |
6 other studies available for deferoxamine and Hyperplasia
| Article | Year |
|---|---|
Free radical attenuation prevents thrombosis and enables photochemical inhibition of vein graft intimal hyperplasia.
Topics: Animals; Antibodies, Monoclonal; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cell | 2004 |
Suppressors of oxygen metabolites fail to reduce vein graft intimal hyperplasia.
Topics: Allopurinol; Animals; Antioxidants; Deferoxamine; Dose-Response Relationship, Drug; Hyperplasia; Mal | 1995 |
Development of gas-exchange surface area in rat lung. The effect of alveolar shape.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Cell Division; Cell Size; Deferoxamine | 1994 |
Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Carotid Artery, Common; Deferoxamine; Hyperpla | 1996 |
High dose nicotinamide fails to prevent diabetes in BB rats.
Topics: Age Factors; Animals; Autoimmune Diseases; Blood Glucose; Cyclosporine; Deferoxamine; Diabetes Melli | 1989 |
Rapid conversion from aluminium bone disease to hyperparathyroid bone disease by desferrioxamine.
Topics: Adult; Aluminum; Bone Diseases; Deferoxamine; Female; Fractures, Spontaneous; Humans; Hyperparathyro | 1988 |